Viewing Study NCT00417183



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00417183
Status: UNKNOWN
Last Update Posted: 2006-12-29
First Post: 2006-12-22

Brief Title: Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
Sponsor: Eugonia
Organization: Eugonia

Study Overview

Official Title: Randomized Controlled Trial Comparing the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation in Normal Responders
Status: UNKNOWN
Status Verified Date: 2006-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to compare the efficacy of two controlled ovarian stimulation protocols the GnRH agonist protocol widely known as the long protocol and the flexible GnRH antagonist protocol in terms of pregnancy rates and embryological data in infertile patients receiving IVF treatment
Detailed Description: The formulation of controlled ovarian stimulation protocols is one of the primary reasons for the successful development of IVF The long GnRH agonist protocol also known as the gold standard has been widely used with considerable success More recently on the other hand GnRH antagonist provide a new promising approach for endogenous gonadotrophin suppression by blocking the GnRH receptor There is conflicting data in the literature regarding the relative merits of the two ovarian stimulation protocols

COMPARISON Pregnancy rates and embryological data will by assessed in IVF patients treated with either the long GnRH agonist Arvekap or the flexible GnRH antagonist Ganirelix protocol

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None